Rocket Pharmaceuticals, Inc.
RCKT
$3.39
-$0.15-4.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.60% | -3.49% | -5.35% | -2.15% | -1.91% |
| Total Depreciation and Amortization | 24.03% | 31.66% | 32.08% | 28.93% | 22.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.77% | 11.98% | 20.83% | -4.09% | -2.16% |
| Change in Net Operating Assets | -70.67% | -76.62% | -73.30% | 432.90% | 604.18% |
| Cash from Operations | -3.36% | -7.44% | -7.60% | 13.30% | 5.35% |
| Capital Expenditure | 82.58% | 72.88% | 64.33% | 31.04% | -24.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.21% | 494.55% | 268.53% | 141.56% | 109.27% |
| Cash from Investing | 880.45% | 246.85% | 234.30% | 143.70% | 97.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -4.97% | -3.50% | -10.87% | -98.96% | 23.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.85% | -3.50% | -10.87% | -98.96% | 23.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.57% | 149.64% | 227.36% | -651.84% | 95.46% |